Free Trial
NYSE:BHC

Bausch Health Companies (BHC) Stock Price, News & Analysis

Bausch Health Companies logo
$5.42 -0.06 (-1.09%)
Closing price 04/25/2025 03:59 PM Eastern
Extended Trading
$5.42 +0.00 (+0.09%)
As of 04/25/2025 06:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Bausch Health Companies Stock (NYSE:BHC)

Key Stats

Today's Range
$5.32
$5.48
50-Day Range
$4.33
$7.71
52-Week Range
$3.96
$9.85
Volume
1.35 million shs
Average Volume
2.71 million shs
Market Capitalization
$1.99 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.17
Consensus Rating
Reduce

Company Overview

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Bausch Health Companies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
81st Percentile Overall Score

BHC MarketRank™: 

Bausch Health Companies scored higher than 81% of companies evaluated by MarketBeat, and ranked 184th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Bausch Health Companies has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no buy ratings, 6 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Bausch Health Companies has only been the subject of 2 research reports in the past 90 days.

  • Read more about Bausch Health Companies' stock forecast and price target.
  • Earnings Growth

    Earnings for Bausch Health Companies are expected to grow by 5.67% in the coming year, from $4.41 to $4.66 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Bausch Health Companies is -45.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Bausch Health Companies is -45.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Growth Ratio

    Bausch Health Companies has a PEG Ratio of 0.37. PEG Ratios below 1 indicate that a company could be undervalued.

  • Read more about Bausch Health Companies' valuation and earnings.
  • Percentage of Shares Shorted

    3.09% of the float of Bausch Health Companies has been sold short.
  • Short Interest Ratio / Days to Cover

    Bausch Health Companies has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bausch Health Companies has recently increased by 14.90%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Bausch Health Companies does not currently pay a dividend.

  • Dividend Growth

    Bausch Health Companies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.09% of the float of Bausch Health Companies has been sold short.
  • Short Interest Ratio / Days to Cover

    Bausch Health Companies has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Bausch Health Companies has recently increased by 14.90%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Bausch Health Companies has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Bausch Health Companies this week, compared to 4 articles on an average week.
  • Search Interest

    Only 6 people have searched for BHC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Bausch Health Companies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 8.12% of the stock of Bausch Health Companies is held by insiders.

  • Percentage Held by Institutions

    78.65% of the stock of Bausch Health Companies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Bausch Health Companies' insider trading history.
Receive BHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter.

BHC Stock News Headlines

Bausch Health announces launch of Solta Medical’s Fraxel FTX
Claim Your FREE Protection Guide
In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code... And since then, "in the know" patriots have quietly used this same "Trump loophole" to shield their life savings from the economic chaos. But with Trump now forcefully bringing back millions of manufacturing jobs from Mexico, China, and the entire BRICS anti-dollar coalition...
See More Headlines

BHC Stock Analysis - Frequently Asked Questions

Bausch Health Companies' stock was trading at $8.06 on January 1st, 2025. Since then, BHC shares have decreased by 32.8% and is now trading at $5.42.
View the best growth stocks for 2025 here
.

Bausch Health Companies Inc. (NYSE:BHC) announced its quarterly earnings results on Wednesday, February, 19th. The company reported $1.21 earnings per share for the quarter, missing the consensus estimate of $1.65 by $0.44. The firm earned $2.56 billion during the quarter, compared to analyst estimates of $2.51 billion. Bausch Health Companies had a negative trailing twelve-month return on equity of 577.82% and a negative net margin of 0.48%.
Read the conference call transcript
.

Top institutional shareholders of Bausch Health Companies include SG Americas Securities LLC (0.78%), Intact Investment Management Inc. (0.05%), Range Financial Group LLC (0.04%) and Kendall Capital Management.
View institutional ownership trends
.

Shares of BHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Alibaba Group (BABA), Tesla (TSLA), Bristol-Myers Squibb (BMY) and Gilead Sciences (GILD).

Company Calendar

Last Earnings
2/19/2025
Today
4/26/2025
Next Earnings (Estimated)
4/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NYSE:BHC
Employees
19,900
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$7.17
High Stock Price Target
$8.50
Low Stock Price Target
$3.00
Potential Upside/Downside
+32.2%
Consensus Rating
Reduce
Rating Score (0-4)
1.86
Research Coverage
7 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
1.23
P/E Growth
0.37
Net Income
$-46,000,000.00
Pretax Margin
1.74%

Debt

Sales & Book Value

Annual Sales
$9.63 billion
Cash Flow
$5.77 per share
Price / Cash Flow
0.94
Book Value
($0.89) per share
Price / Book
-6.09

Miscellaneous

Free Float
338,058,000
Market Cap
$1.99 billion
Optionable
Optionable
Beta
0.43
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:BHC) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners